| Patents for C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008) |
|---|
| 04/01/2004 | WO2003087765A3 System for tracing animal products |
| 04/01/2004 | WO2003061576A3 Deazapurine nucleoside analogs and their use as therapeutic agents |
| 04/01/2004 | WO2002076402A3 Fatty amine drug conjugates |
| 04/01/2004 | US20040063926 L-nucleic acid derivative and processes for the synthesis thereof |
| 04/01/2004 | US20040063668 Antiviral agent; hepatitis B; such as ((1-((6-amino-9H-purin-9-yl)methyl)cyclopropyl)oxy)methylphosphonic acid |
| 04/01/2004 | US20040063659 Novel 2'-halomethylidene,2'-ethenylidene and 2'-ethynyl cytidine, uridine and guanosine derivatives |
| 04/01/2004 | US20040063658 Such as 9-(2'-C-methyl-beta-D-ribofuranosyl)-6-bromopurine |
| 04/01/2004 | US20040063651 3'-deoxy-3'-fluorouridine and 1-(3'-deoxy-fluoro-beta-ribofuranosyl)-uracil derivatives; reduced side effects; selectively inhibits viral RNA dependent RNA polymerase |
| 04/01/2004 | US20040063622 Methods and compositions for treating flaviviruses and pestiviruses |
| 03/31/2004 | EP1402024A2 Templated molecules and methods for using such molecules |
| 03/31/2004 | EP1401851A1 Two-stage protective groups for the synthesis of biopolymers |
| 03/31/2004 | EP1401850A1 Nucleoside derivatives for library preparation |
| 03/31/2004 | EP1401454A2 Use of corrinoids in the treatment of skin diseases |
| 03/31/2004 | EP1209166B1 Novel a-500359 derivatives |
| 03/31/2004 | EP1019453B1 Aromatic-substituted xanthene dyes |
| 03/30/2004 | US6713623 Useful as intermediates in the synthesis of biologically active compounds |
| 03/30/2004 | US6713616 Detecting binding |
| 03/30/2004 | US6713448 Substantially pure glycopeptide antibiotics AC-98-1; AC-98-2; AC-98-3; AC-98-4 and AC-98-5 |
| 03/30/2004 | CA2057760C Salinomycin biomass granules which are free-flowing and dust-free and have unrestricted bioavailability of active substance, and a process for the production thereof |
| 03/25/2004 | WO2004024314A2 A population of nucleic acids including a subpopulation of lna oligomers |
| 03/25/2004 | WO2004024283A2 Apparatus and method for preparative scale purification of nucleic acids |
| 03/25/2004 | WO2003066645A3 Base-labeled nucleosides and nucleotides |
| 03/25/2004 | WO2003052134A3 Oligonucleotides comprising intercalator pseudonucleotide(s) for detection of nucleic acids and mutants hereof |
| 03/25/2004 | US20040059105 Triazole linked carbohydrates |
| 03/25/2004 | US20040059104 Nucleotide mimics and their prodrugs |
| 03/25/2004 | US20040058893 Sexual disorders, aids, hepatitis virus |
| 03/25/2004 | US20040058884 Detecting diseases by Selex method; anticancer agents |
| 03/25/2004 | US20040058322 Conjugates between a minor groove binding the trimer of 1,2-dihydro- (3H)-pyrrolo(3,3-e)indole-7-carboxylate and an oligonucleotide and forms stable hybrids with complementary target sequence |
| 03/25/2004 | US20040055956 Includes valving to enable the excess diluent to move from the purification column into the output reservoir to provide removed diluent |
| 03/25/2004 | CA2498518A1 Apparatus and method for preparative scale purification of nucleic acids |
| 03/24/2004 | EP1400241A1 Fused cyclic compounds and medicinal use thereof |
| 03/24/2004 | EP1399176A1 Substantially pure glycopeptide antibiotics ac-98-1; ac-98-2; ac-98-3; ac-98-4 and ac-98-5 |
| 03/24/2004 | EP1315508B1 Purine ribosides as antiarrhythmics |
| 03/24/2004 | EP1218542B1 Methods and compositions for linear isothermal amplification of polynucleotide sequences |
| 03/18/2004 | WO2004022573A2 Adenosine a3 receptor agonists |
| 03/18/2004 | WO2004007751A3 Nucleic acid labeling methods |
| 03/18/2004 | WO2004006887A3 Composition and methods for the treatment of skin disorders |
| 03/18/2004 | WO2003093290A3 Nucleoside derivatives for treating hepatitis c virus infection |
| 03/18/2004 | WO2003052053A3 Nucleoside libraries and compounds by mcc combinatorial strategies on solid support |
| 03/18/2004 | US20040054156 Method and reagent for inhibiting hepatitis B viral replication |
| 03/18/2004 | US20040054155 Oligonucleotide compositions with enhanced efficiency |
| 03/18/2004 | US20040053944 Antiprotozoa agents; 4-pyrrolidine pyrrolo(3,2-d)pyrimidine and 4-pyrrolidine pyrazolo(4,3-d)pyrimidine derivatives |
| 03/18/2004 | US20040053891 For treatment of infections by Varicella Zoster Virus, Epstein Barr Virus and Kaposi's Sarcoma virus |
| 03/18/2004 | US20040053883 Crystalline forms of pyrimidine nucleoside derivative |
| 03/18/2004 | US20040053881 Adenosine derivatives and use thereof |
| 03/18/2004 | US20040053825 Inhibit adenylyl cyclase in cells but have little effect on isolated adenylyl cyclase; useful as prodrugs for inhibiting adenylyl cyclase and lowering 3':5'-cAMP in cells, thereby inhibiting adenylyl cyclase dependent effects within cells |
| 03/18/2004 | US20040053287 Reagents for monitoring nucleic acid amplification and methods of using same |
| 03/18/2004 | US20040053217 Using conjugate agents comprise of photoreactive moiety to identify preferential micro and/or macromolecules in heterologous mixtures |
| 03/18/2004 | DE10241116A1 Verfahren zur Gewinnung von Uridin aus Melasse A process for the recovery of uridine from molasses |
| 03/17/2004 | EP1397379A1 Adenosine derivative in polymorph i form |
| 03/17/2004 | EP1397378A1 Adenosine derivative in polymorph ii form |
| 03/17/2004 | EP1397377A1 Calix 4]arene-nucleoside and calix 4]arene-oligonucleotide hybrids |
| 03/17/2004 | EP1397147A1 Use of adenosine a1 agonists in the treatment of emesis |
| 03/17/2004 | EP1397140A2 Combination of an adenosine a2a-receptor agonist and tiotropium or a derivative thereof for treating obstructive airways |
| 03/17/2004 | EP1012154B1 Salts of di(uridine 5'-tetraphosphate), method for preparation and uses thereof |
| 03/17/2004 | EP0731807B1 N-2 substituted purines |
| 03/17/2004 | CN1482914A Remedies for hepatitis c |
| 03/17/2004 | CN1482913A Purine ribosides as antiarrhythmics |
| 03/17/2004 | CN1482908A Phase transfer catalyzed glycosidation of an indolocarbazole |
| 03/17/2004 | CN1482122A Intermediates for producing 2-thiosubstituted carbapenems |
| 03/16/2004 | US6706879 Contain additional sites for attachment to biomolecules. |
| 03/11/2004 | WO2004020654A2 Solid phase based nucleic acid assays combining high affinity and high specificity |
| 03/11/2004 | WO2003068164A3 Dosing regimen for gemcitabine hcv therapy |
| 03/11/2004 | WO2003068162A3 Modified fluorinated nucleoside analogues |
| 03/11/2004 | WO2003034978A3 Antidiabetic 2-substituted-5'-o- (1-boranotriphosphate) adenosine derivatives |
| 03/11/2004 | US20040049008 Templated molecules and methods for using such molecules |
| 03/11/2004 | US20040048845 Containing indolecarbazole compounds, such as staurosporine. |
| 03/11/2004 | US20040048826 Oligonucleotides containing 2'-0-modified purines |
| 03/11/2004 | US20040047916 Compositions and methods for the treatme of primary and metastatic neoplastic disea using arsenic compounds |
| 03/11/2004 | CA2497297A1 Solid phase based nucleic acid assays combining high affinity and high specificity |
| 03/10/2004 | EP1396497A1 Process for the recovery of uridine from molasses |
| 03/10/2004 | EP1395266A1 Antiviral nucleoside derivatives |
| 03/10/2004 | EP1274713B1 Anti-viral pyrimidine nucleoside analogues |
| 03/10/2004 | EP1071693B1 Novel crystalline forms of an antiviral benzimidazole compound |
| 03/10/2004 | CN1141314C 2',3'-O-isopropylidennucleoside 5'-thiophosphamino acid ester compound |
| 03/09/2004 | US6703396 Cis-4-amino-5-fluoro-1-(2-hydroxymethyl-1,3-oxathiolane-5-yl) -(1h)-pyrimidin-2-one |
| 03/09/2004 | US6703376 Administering to the airways of the patient a uridine phosphate such as uridine 5'triphosphate or di(uridine5') tetraphosphate for promoting drainage of mucous secretions in the congested airways of a bedridden/immobilized patient |
| 03/09/2004 | US6703374 Activated by thymidylate synthase and/or thymidine kinase enzyme; antitumor agents; diagnosis |
| 03/09/2004 | US6703373 Indolopyrrolocarbazole derivatives and antitumor agents |
| 03/09/2004 | US6702705 Prodrugs activated by targeted catalytic proteins |
| 03/04/2004 | WO2004019002A2 Fluorescent glycosides and methods for their use |
| 03/04/2004 | WO2004018712A1 OLIGONUCLEOTIDE TAGGED NUCLEOSIDE TRIPHOSPHATES (OTNTPs) FOR GENETIC ANALYSIS |
| 03/04/2004 | WO2004018497A2 Modified nucleotides for polynucleotide sequencing |
| 03/04/2004 | WO2004018496A1 Inhibitors of nucleoside phosphorylases and nucleosidases |
| 03/04/2004 | WO2004018495A1 Process for producing indolopyrrolocarbazole derivative |
| 03/04/2004 | WO2004018494A1 4'-thionucleotide |
| 03/04/2004 | WO2004018493A1 Labelled nucleotides |
| 03/04/2004 | WO2004018492A1 Process for producing a ribofuranose |
| 03/04/2004 | WO2004018490A1 Process for the preparation of 9-beta-anomeric nucleoside analogs |
| 03/04/2004 | WO2003106475A3 Process for the preparation of heterocyclyl substituted adenosine derivatives |
| 03/04/2004 | WO2002068442A8 Salts of avermectins substituted in the 4'-position and having pesticidal properties |
| 03/04/2004 | US20040044190 Purification of oligomers |
| 03/04/2004 | US20040043960 Partial and full agonists of A1 adenosine receptors |
| 03/04/2004 | US20040043955 Anticoagulants; cardiovascular disorders; nucleotidase inhibitor |
| 03/04/2004 | US20040043951 Hydrogelation agents |
| 03/04/2004 | US20040043923 Detection, calibration binding of ligand to nucleic acids |
| 03/04/2004 | CA2496479A1 Process for producing indolopyrrolocarbazole derivative |
| 03/04/2004 | CA2496268A1 Oligonucleotide tagged nucleoside triphosphates (otntps) for genetic analysis |
| 03/04/2004 | CA2493454A1 Process for producing a ribofuranose |
| 03/03/2004 | EP1394161A1 L−ASCORBIC ACID−2−O−MALEIC ACID−A−TOCOPHEROL DIESTER 1−PROPANOL ADDUCT AND PROCESS FOR PRODUCING THE SAME |